EMPACON MET 5/500 TABLET

PACKAGING TYPE: 6×10 Blister (6 Strips In 1 Box)
COMPOSITION: Each Film Coated Tablet Contains: Empagliflozin 5 Mg, Metformin Hydrochloride 500 Mg, Excipients Q.s. Colour: Approved colour used.
FORMULATION: Tablet
Description: EMPACON MET 5/500 TABLET is a combination of two anti-diabetic agents: Empagliflozin (5 mg), a sodium-glucose co-transporter-2 (SGLT2) inhibitor, and Metformin Hydrochloride (500 mg), a biguanide. This formulation helps lower blood glucose levels by enhancing glucose excretion via urine and decreasing hepatic glucose production and intestinal glucose absorption, while improving insulin sensitivity. It is mainly prescribed for managing Type 2 Diabetes Mellitus, especially when monotherapy is insufficient.

Jardiance Met 5mg/500mg Tablet (Boehringer Ingelheim)
Side Effects: – Frequent urination
– Dehydration
– Low blood sugar (especially with insulin or sulfonylureas)
– Nausea or vomiting
– Abdominal discomfort
– Genital fungal infections
– Urinary tract infections
– Lactic acidosis (rare but serious)
– Increased cholesterol levels
How to Use: – Take the tablet with food to reduce gastrointestinal side effects.
– Swallow whole with a glass of water; do not crush or chew.
– Maintain regular meals and avoid skipping doses.
– Use under the supervision of a registered healthcare provider.
Precaution: – Not for use in patients with Type 1 Diabetes or diabetic ketoacidosis.
– Use cautiously in patients with renal impairment.
– Monitor liver and kidney functions regularly.
– Avoid alcohol, as it may increase the risk of lactic acidosis.
– Not recommended during pregnancy or breastfeeding without medical advice.
– Stay hydrated to prevent dehydration due to increased urination.
Product Benefits: – Dual mechanism improves overall glycemic control
– Reduces HbA1c levels significantly
– Promotes weight loss or weight neutrality
– Helps lower systolic blood pressure
– Low risk of hypoglycemia when used without sulfonylureas or insulin
– Cardiova
Expiry Date: 2027-03-31